Pontieri, L, Blinkenberg, M, Bramow, S, Papp, V, Rasmussen, P V, Kant, M, Schäfer, J, Mathiesen, H K, Jensen, M B, Sirakov, G, Berg, J M, Kopp, T I, Joensen, H, Sellebjerg, F & Magyari, M 2022, ' Ocrelizumab treatment in multiple sclerosis : A Danish population-based cohort study ', European Journal of Neurology, vol. 29, no. 2, pp. 496-504 . https://doi.org/10.1111/ene.15142
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, Van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in the Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820 PLoS ONE, Vol 16, Iss 5, p e0250820 (2021) Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbaek, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLoS ONE, vol. 16, no. 5, 0250820 . https://doi.org/10.1371/journal.pone.0250820 PLoS ONE Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820
Buron, M D, Chalmer, T A, Sellebjerg, F, Barzinji, I, Christensen, J R, Christensen, M K, Hansen, V, Illes, Z, Jensen, H B, Kant, M, Papp, V, Petersen, T, Rasmussen, P V, Schäfer, J, Theódórsdóttir, Á, Weglewski, A, Sorensen, P S & Magyari, M 2020, ' Initial high-efficacy disease-modifying therapy in multiple sclerosis : A nationwide cohort study ', Neurology, vol. 95, no. 8, pp. e1041-e1051 . https://doi.org/10.1212/WNL.0000000000010135